A carregar...
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Since the approval in 2017 and the outstanding success of Kymriah® and Yescarta®, the number of clinical trials investigating the safety and efficacy of chimeric antigen receptor-modified autologous T cells has been constantly rising. Currently, more than 200 clinical trials are listed on clinicaltr...
Na minha lista:
| Publicado no: | Transfus Med Hemother |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558329/ https://ncbi.nlm.nih.gov/pubmed/31244577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495771 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|